Àngels Orcau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Àngels Orcau has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Joan Artur Caylà
Tuberculosis Research Unit Foundation of Barcelona, 08008 Barcelona, Spain
7 shared publications - Martí Casals
Programa Integrado de Investigación en Tuberculosis (PII-TB) de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Barcelona, Spain.
3 shared publications - Joan-Pau Millet
Serveis Clinics, Barcelona, Spain; Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
2 shared publications - Ana Ayestarán
Hospital de Barcelona. Societat Cooperativa d'Installacions Assistencials Sanitaries (SCIAS)
1 shared publication Anna Rodés
1 shared publication- Antoni Pérez-Navarro
Faculty of Computer Sciences, Multimedia and Telecommunication, Universitat Oberta de Catalunya, Barcelona, Spain
1 shared publication
Latest Publications
- 29 May 2017
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 65 (7) , 1136-1143
Healthcare-Associated Mycobacterium bovis-Bacille Calmette-Guérin (BCG) Infection in Cancer Patients Without Prior BCG Instillation.
Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely used as adjunctive therapy for superficial bladder cancer. Intravesical administration of BCG has been associated with systemic infection. Disseminated infection due to M. bovis is otherwise uncommon. After identification of 3 patients with healthcare-associated BCG infection who had never received intravesical BCG administration, an epidemiologic study was performed. All patients with healthcare-associated BCG infection in the Barcelona tuberculosis (TB) program were reviewed from 1 January 2005 to 31 December 2015, searching for infections caused by M. bovis–BCG. Patients with healthcare-associated BCG infection who had not received intravesical BCG instillation were selected and the source of infection was investigated. Nine oncology patients with infection caused by M. bovis–BCG were studied. All had permanent central venous catheters. Catheter maintenance was performed at 4 different outpatient clinics in the same room in which other patients underwent BCG instillations for bladder cancer without required biological precautions. All patients developed pulmonary TB, either alone or with extrapulmonary disease. Catheter-related infection was considered the mechanism of acquisition based on the epidemiologic association and positive catheter cultures for BCG in patients in whom mycobacterial cultures were performed. Physicians should be alerted to the possibility of TB due to nosocomially acquired, catheter-related infections with M. bovis–BCG in patients with indwelling catheters. This problem may be more common than expected in centers providing BCG therapy for bladder cancer without adequate precautions.
- 29 May 2017
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 65 (7) , 1136-1143
Healthcare-Associated Mycobacterium bovis-Bacille Calmette-Guérin (BCG) Infection in Cancer Patients Without Prior BCG Instillation.
Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely used as adjunctive therapy for superficial bladder cancer. Intravesical administration of BCG has been associated with systemic infection. Disseminated infection due to M. bovis is otherwise uncommon. After identification of 3 patients with healthcare-associated BCG infection who had never received intravesical BCG administration, an epidemiologic study was performed. All patients with healthcare-associated BCG infection in the Barcelona tuberculosis (TB) program were reviewed from 1 January 2005 to 31 December 2015, searching for infections caused by M. bovis–BCG. Patients with healthcare-associated BCG infection who had not received intravesical BCG instillation were selected and the source of infection was investigated. Nine oncology patients with infection caused by M. bovis–BCG were studied. All had permanent central venous catheters. Catheter maintenance was performed at 4 different outpatient clinics in the same room in which other patients underwent BCG instillations for bladder cancer without required biological precautions. All patients developed pulmonary TB, either alone or with extrapulmonary disease. Catheter-related infection was considered the mechanism of acquisition based on the epidemiologic association and positive catheter cultures for BCG in patients in whom mycobacterial cultures were performed. Physicians should be alerted to the possibility of TB due to nosocomially acquired, catheter-related infections with M. bovis–BCG in patients with indwelling catheters. This problem may be more common than expected in centers providing BCG therapy for bladder cancer without adequate precautions.
- Open Access
- 1 March 2016
- Published by Elsevier in Gaceta Sanitaria
- Vol. 30 (2) , 144-147
La hospitalización terapéutica obligatoria en el control de la tuberculosis
- 1 March 2016
- Published by Elsevier in Gaceta Sanitaria
- Vol. 30 (2) , 144-147
Open AccessLa hospitalización terapéutica obligatoria en el control de la tuberculosis
- 1 July 2013
- Published by Elsevier in Tuberculosis
- Vol. 93 (4) , 456-460
Immigrants do not transmit tuberculosis more than indigenous patients in Catalonia (Spain)
- 1 July 2013
- Published by Elsevier in Tuberculosis
- Vol. 93 (4) , 456-460
Immigrants do not transmit tuberculosis more than indigenous patients in Catalonia (Spain)
- 1 April 2013
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 31 (4) , 227-229
Recurrences in tuberculosis in a cohort of human immunodeficiency virus-infected patients: The influence of highly active antiretroviral therapy
- 1 April 2013
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 31 (4) , 227-229
Recurrences in tuberculosis in a cohort of human immunodeficiency virus-infected patients: The influence of highly active antiretroviral therapy
- Open Access
- 6 March 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 158
Community health workers improve contact tracing among immigrants with tuberculosis in Barcelona
The important increase in immigration during recent years has changed the epidemiology and control strategies for tuberculosis (TB) in many places. This study evaluates the effectiveness of intervention with community health workers (CHW) to improve contact tracing among immigrants.
- 6 March 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 158
Open AccessCommunity health workers improve contact tracing among immigrants with tuberculosis in Barcelona
The important increase in immigration during recent years has changed the epidemiology and control strategies for tuberculosis (TB) in many places. This study evaluates the effectiveness of intervention with community health workers (CHW) to improve contact tracing among immigrants.
- Open Access
- 29 November 2011
- Published by Springer Nature in International Journal of Health Geographics
- Vol. 10 (1) , 62
Development of spatial density maps based on geoprocessing web services: application to tuberculosis incidence in Barcelona, Spain
Background: Health professionals and authorities strive to cope with heterogeneous data, services, and statistical models to support decision making on public health. Sophisticated analysis and distributed processing capabilities over geocoded epidemiological data are seen as driving factors to speed up control and decision making in these health risk situations. In this context, recent Web technologies and standards-based web services deployed on geospatial information infrastructures have rapidly become an efficient way to access, share, process, and visualize geocoded health-related information. Methods: Data used on this study is based on Tuberculosis (TB) cases registered in Barcelona city during 2009. Residential addresses are geocoded and loaded into a spatial database that acts as a backend database. The web-based application architecture and geoprocessing web services are designed according to the Representational State Transfer (REST) principles. These web processing services produce spatial density maps against the backend database. Results: The results are focused on the use of the proposed web-based application to the analysis of TB cases in Barcelona. The application produces spatial density maps to ease the monitoring and decision making process by health professionals. We also include a discussion of how spatial density maps may be useful for health practitioners in such contexts. Conclusions: In this paper, we developed web-based client application and a set of geoprocessing web services to support specific health-spatial requirements. Spatial density maps of TB incidence were generated to help health professionals in analysis and decision-making tasks. The combined use of geographic information tools, map viewers, and geoprocessing services leads to interesting possibilities in handling health data in a spatial manner. In particular, the use of spatial density maps has been effective to identify the most affected areas and its spatial impact. This study is an attempt to demonstrate how web processing services together with web-based mapping capabilities suit the needs of health practitioners in epidemiological analysis scenarios.
- 29 November 2011
- Published by Springer Nature in International Journal of Health Geographics
- Vol. 10 (1) , 62
Open AccessDevelopment of spatial density maps based on geoprocessing web services: application to tuberculosis incidence in Barcelona, Spain
Background: Health professionals and authorities strive to cope with heterogeneous data, services, and statistical models to support decision making on public health. Sophisticated analysis and distributed processing capabilities over geocoded epidemiological data are seen as driving factors to speed up control and decision making in these health risk situations. In this context, recent Web technologies and standards-based web services deployed on geospatial information infrastructures have rapidly become an efficient way to access, share, process, and visualize geocoded health-related information. Methods: Data used on this study is based on Tuberculosis (TB) cases registered in Barcelona city during 2009. Residential addresses are geocoded and loaded into a spatial database that acts as a backend database. The web-based application architecture and geoprocessing web services are designed according to the Representational State Transfer (REST) principles. These web processing services produce spatial density maps against the backend database. Results: The results are focused on the use of the proposed web-based application to the analysis of TB cases in Barcelona. The application produces spatial density maps to ease the monitoring and decision making process by health professionals. We also include a discussion of how spatial density maps may be useful for health practitioners in such contexts. Conclusions: In this paper, we developed web-based client application and a set of geoprocessing web services to support specific health-spatial requirements. Spatial density maps of TB incidence were generated to help health professionals in analysis and decision-making tasks. The combined use of geographic information tools, map viewers, and geoprocessing services leads to interesting possibilities in handling health data in a spatial manner. In particular, the use of spatial density maps has been effective to identify the most affected areas and its spatial impact. This study is an attempt to demonstrate how web processing services together with web-based mapping capabilities suit the needs of health practitioners in epidemiological analysis scenarios.
- 1 October 2003
- Published by Elsevier in Medicina Clinica
- Vol. 121 (13) , 494-495
Estudio de contactos en el siglo XXI: se precisan innovaciones
- 1 October 2003
- Published by Elsevier in Medicina Clinica
- Vol. 121 (13) , 494-495
Estudio de contactos en el siglo XXI: se precisan innovaciones